CO4990966A1 - Compuestos de tiourea y benzamida, composiciones y metodos para tratar y prevenir enfermedades inflamatorias y arteros- clerosis - Google Patents
Compuestos de tiourea y benzamida, composiciones y metodos para tratar y prevenir enfermedades inflamatorias y arteros- clerosisInfo
- Publication number
- CO4990966A1 CO4990966A1 CO98076093A CO98076093A CO4990966A1 CO 4990966 A1 CO4990966 A1 CO 4990966A1 CO 98076093 A CO98076093 A CO 98076093A CO 98076093 A CO98076093 A CO 98076093A CO 4990966 A1 CO4990966 A1 CO 4990966A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- substituted
- aryl
- cycloalkyl
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/63—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C335/22—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Compuestos CARACTERIZADOS porque tienen la Fórmula Idondecada n es independientemente 0 a 3;Q es alquilo C1 -C6 ,heteroarilo, heteroarilo sustituido, -NR´, o cicloalquilo; cada R´ es independientemente hidrógeno o alquilo C1 -C6 ;Re es - 2 -heteroarilo sustituido, naftilo, bencilo o dansilo;cada uno de R1 , R2 , R3 , R4 , R5 , R7 , R8 , Ra , Rb , Rc , y Rd es independientemente hidrógeno, -O alquilo, C1 -C6 , -S alquilo C1 -C6 , hidrógeno, alquilo C1 -C6 , -OH, CF3 , -NO2 , -CN, CO2 H, OCF3 , -CO2 , alquilo C1 -C6 , SO3 H, -SO3 -metal alcalino -NH2 , -NH alquilo C1 -C6 O O ½ ½-N(C alquilo C1 -C6 )2 -OC alquilo C1 -C6 , -CO2 alquilo C1 -C6 -SO3 H,-SO3 metal alcalino, -CN -CH2 -halógeno, CH2 -CH2 ½ ½O O ½ ½heteroarilo, heteroarilo sustituido, arilo, arilo sustituido, cicloalquilo, cicloalquilo sustituido, heterocicloalquilo, heterocicloalquilo sustituido, benzoilo, O½C alquilo C1 -C6 O O½ ½ -OCH, -OC alquilo C1 -C6 -SO3 H, -SO3 NR´R´, -CHO, -SO2 NH2 o -NR´R´; o las sales farmacéuticamente aceptables de ellos.O½siempre que cuando Y es -CO-,Q no sea alquilo C1 -C6 ; además siempre que cuando X es O½-CNH- e Y es NH, Rb no sea -OH; además siempre que cuando X e Y sonO½-NHC- Re y Q no sean fenilo sin sustituir; además siempre que O O½ ½ cuando Y es -NHC- y X es -NHCO-, Re y Q no sean ambos arilo; además siempre que cuando Y es SO2 NH- o -SO2 N alquilo C1 -C6 yO O½ ½X es CNH ó CN alquilo C1 -C6 , Q y Re no sean ambos fenilo sin sustituir; además siempre que cuando Y esO O O½ ½ ½-CNH ó -CN alquilo C1 -C6 y X es-NC, ½HRe sea fenilo sin sustituir fenilo di- o tri-sustituido; siempre además que cuando Y esO½-NR´CNR´-,Q no sea arilo sin sustituir.donde heteroarilo ó arilo cicloalquilo o heterocicloalquilo sustituido significa que dichos ciclos tienen uno o más sustituyentes seleccionados entre halógeno, alquilo C1 -C8 , -CN, CF3 , -NO2 -NH2 , -NH(alquilo C1 -C8 ), -N(alquilo C1 -C8 ),-O-(alquilo C1 -C8 ) y -OH.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6860497P | 1997-12-23 | 1997-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4990966A1 true CO4990966A1 (es) | 2000-12-26 |
Family
ID=22083601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98076093A CO4990966A1 (es) | 1997-12-23 | 1998-12-22 | Compuestos de tiourea y benzamida, composiciones y metodos para tratar y prevenir enfermedades inflamatorias y arteros- clerosis |
Country Status (17)
Country | Link |
---|---|
US (2) | US6268387B1 (es) |
EP (1) | EP1042276B1 (es) |
JP (1) | JP2001526255A (es) |
KR (1) | KR20010033470A (es) |
AR (1) | AR024826A1 (es) |
AT (1) | ATE282591T1 (es) |
AU (1) | AU1529799A (es) |
BR (1) | BR9814327A (es) |
CA (1) | CA2300197A1 (es) |
CO (1) | CO4990966A1 (es) |
DE (1) | DE69827664T2 (es) |
ES (1) | ES2234169T3 (es) |
NZ (1) | NZ502963A (es) |
PE (1) | PE20000064A1 (es) |
UY (1) | UY25322A1 (es) |
WO (1) | WO1999032433A1 (es) |
ZA (1) | ZA9811805B (es) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6563802B2 (en) | 1998-06-22 | 2003-05-13 | Intel Corporation | Echo cancellation with dynamic latency adjustment |
DE69908156T2 (de) | 1998-09-23 | 2003-12-24 | Tularik Inc | Arylsulfonanilid-harnstoffe |
WO2001047921A1 (en) * | 1999-12-28 | 2001-07-05 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
EP1294687A2 (en) | 2000-06-14 | 2003-03-26 | Warner-Lambert Company | 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
UA76977C2 (en) | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
AU2002331706B2 (en) | 2001-08-15 | 2009-01-22 | E.I. Du Pont De Nemours And Company | Ortho-substituted aryl amides for controlling invertebrate pests |
WO2003062226A1 (en) | 2002-01-22 | 2003-07-31 | E. I. Du Pont De Nemours And Company | Quinazoline(di) ones for invertebrate pest control |
MXPA04007611A (es) * | 2002-02-08 | 2005-05-27 | Hoffmann La Roche | Metodo para tratar y prevenir perdida osea. |
CA2485681C (en) | 2002-05-24 | 2012-10-16 | Millennium Pharmaceuticals, Inc. | Ccr9 inhibitors and methods of use thereof |
KR20040018295A (ko) * | 2002-08-22 | 2004-03-03 | 임철부 | 항암 활성을 갖는 티오우레이도 세라마이드 유도체 및 이화합물을 함유하는 약학적 조성물 |
US6812355B2 (en) | 2002-10-22 | 2004-11-02 | Sekhsaria Chemicals Limited | Process for the manufacture of citalopram hydrobromide from 5-bromophthalide |
FR2846326A1 (fr) * | 2002-10-29 | 2004-04-30 | Isochem Sa | Procede de purification des n-carboxyanhydrides |
EP2256116A3 (en) | 2002-11-18 | 2011-11-16 | ChemoCentryx, Inc. | Aryl sulfonamides |
US7227035B2 (en) | 2002-11-18 | 2007-06-05 | Chemocentryx | Bis-aryl sulfonamides |
US7741519B2 (en) | 2007-04-23 | 2010-06-22 | Chemocentryx, Inc. | Bis-aryl sulfonamides |
US7420055B2 (en) | 2002-11-18 | 2008-09-02 | Chemocentryx, Inc. | Aryl sulfonamides |
CA2506415A1 (en) | 2002-11-19 | 2004-06-03 | Achillion Pharmaceuticals, Inc. | Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
KR100555655B1 (ko) * | 2002-11-20 | 2006-03-03 | 임철부 | 항암 활성을 갖는 우레이도 또는 티오우레이도 유도체 및이 화합물을 함유하는 약학조성물 |
CA2515544A1 (en) * | 2003-02-11 | 2004-08-26 | Kemia Inc. | Compounds for the treatment of viral infection |
TW200529812A (en) | 2003-12-26 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Benzamide derivatives |
US7262318B2 (en) * | 2004-03-10 | 2007-08-28 | Pfizer, Inc. | Substituted heteroaryl- and phenylsulfamoyl compounds |
TW200600492A (en) * | 2004-05-18 | 2006-01-01 | Achillion Pharmaceuticals Inc | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
US20050288340A1 (en) * | 2004-06-29 | 2005-12-29 | Pfizer Inc | Substituted heteroaryl- and phenylsulfamoyl compounds |
EP1775283A4 (en) * | 2004-07-14 | 2008-12-10 | Japan Tobacco Inc | 3-AMINOBENZAMIDE COMPOUND AND INHIBITORS OF THE ACTIVITY OF VANILLOID RECEPTOR 1 (VR1) |
BRPI0513286A (pt) * | 2004-07-15 | 2008-05-06 | Japan Tobacco Inc | compostos de benzamida condensada e inibidores de atividade de receptor vanilóide subtipo (vr1), suas composições farmacêuticas, pacote comercial, fármaco e respectivos usos |
CN101189210B (zh) * | 2005-06-06 | 2012-06-06 | 霍夫曼-拉罗奇有限公司 | 可用作肝肉碱棕榈酰转移酶(l-cpt1)抑制剂的磺酰胺衍生物 |
ZA200800608B (en) | 2005-06-21 | 2009-06-24 | Mitsui Chemicals Inc | Amide derivative and insecticide containing the same |
US7754717B2 (en) | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
US7464565B2 (en) | 2005-11-29 | 2008-12-16 | Maytag Corporation | Rapid temperature change device for a refrigerator |
US20070155746A1 (en) * | 2005-12-23 | 2007-07-05 | Kalypsys, Inc. | Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases |
US7906508B2 (en) * | 2005-12-28 | 2011-03-15 | Japan Tobacco Inc. | 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity |
WO2008031534A1 (en) | 2006-09-11 | 2008-03-20 | Syngenta Participations Ag | Insecticidal compounds |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
EP2170830B1 (en) | 2007-07-17 | 2014-10-15 | Plexxikon, Inc. | 2-FLUORO-BENZENESULFONAMIDE COMPOUNDS AS Raf KINASE MODULATORS |
FR2926297B1 (fr) | 2008-01-10 | 2013-03-08 | Centre Nat Rech Scient | Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage. |
FR2930552B1 (fr) * | 2008-04-24 | 2012-10-12 | Centre Nat Rech Scient | N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog |
GB0813403D0 (en) | 2008-07-22 | 2008-08-27 | Lectus Therapeutics Ltd | Potassium ion channel modulators & uses thereof |
CN101367749B (zh) * | 2008-09-28 | 2013-04-24 | 中国医学科学院医药生物技术研究所 | 一组胺基苯酰衍生物及其制备方法和应用 |
MY172424A (en) | 2009-04-03 | 2019-11-25 | Hoffmann La Roche | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof |
AU2010303270A1 (en) | 2009-10-09 | 2012-05-03 | Zafgen Corporation | Sulphone compounds for use in the treatment of obesity |
BR112012012156A2 (pt) | 2009-11-06 | 2015-09-08 | Plexxikon Inc | compostos e métodos para modulação de cinase, e indicações para esta |
ES2533065T3 (es) | 2010-07-09 | 2015-04-07 | Pfizer Limited | Bencenosulfonamidas útiles como inhibidores de los canales de sodio |
KR20130043207A (ko) | 2010-07-22 | 2013-04-29 | 자프겐 인크. | 트리시클릭 화합물 및 이의 제조 및 사용 방법 |
TW201216963A (en) * | 2010-09-03 | 2012-05-01 | Forma Therapeutics Inc | Novel compounds and compositions for the inhibition of NAMPT |
JP6058557B2 (ja) | 2011-01-26 | 2017-01-11 | ザフゲン,インコーポレイテッド | テトラゾール化合物ならびにその作製方法および使用方法 |
TR201816421T4 (tr) | 2011-02-07 | 2018-11-21 | Plexxikon Inc | Kinaz modülasyonu için bileşikler ve metotlar ve bunların endikasyonları. |
AR085279A1 (es) | 2011-02-21 | 2013-09-18 | Plexxikon Inc | Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico |
EP2505198A1 (en) | 2011-04-01 | 2012-10-03 | Société Splicos | Compounds for use as therapeutic agents affecting p53 expression and/or activity |
BR112013028665A2 (pt) | 2011-05-06 | 2016-09-06 | Zafgen Inc | compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos |
BR112013028534A2 (pt) | 2011-05-06 | 2016-09-06 | Zafgen Inc | compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos |
BR112013028666A2 (pt) | 2011-05-06 | 2017-08-08 | Zafgen Inc | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo |
JP6035347B2 (ja) | 2012-01-18 | 2016-11-30 | ザフゲン,インコーポレイテッド | 三環式スルホンアミド化合物ならびにその作製および使用方法 |
EP2804856B1 (en) | 2012-01-18 | 2017-03-15 | Zafgen, Inc. | Tricyclic sulfone compounds and methods of making and using same |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
EP2925737B1 (en) | 2012-11-05 | 2017-06-14 | Zafgen, Inc. | Tricyclic compounds for use in the treatment and/or control of obesity |
CN104918615B (zh) | 2012-11-05 | 2018-10-12 | 扎夫根股份有限公司 | 治疗肝病的方法 |
CA2890342A1 (en) | 2012-11-05 | 2014-05-08 | Zafgen, Inc. | Tricyclic compounds and methods of making and using same |
GB201317609D0 (en) | 2013-10-04 | 2013-11-20 | Cancer Rec Tech Ltd | Inhibitor compounds |
JP6156846B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
WO2015184405A1 (en) * | 2014-05-30 | 2015-12-03 | Medivation Technologies, Inc. | Aromatic compounds, compositions and uses thereof |
WO2016029136A1 (en) * | 2014-08-21 | 2016-02-25 | Northwestern University | 3-amidobenzamides and uses thereof for increasing cellular levels of a3g |
US9597332B2 (en) | 2014-12-02 | 2017-03-21 | Novira Therapeutics, Inc. | Sulfide alkyl compounds for HBV treatment |
DK3227262T3 (da) * | 2014-12-02 | 2020-08-10 | Novira Therapeutics Inc | Sulfidalkyl og pyridyl-revers-sulfonamidforbindelser til hbv-behandling |
US9765050B2 (en) | 2014-12-30 | 2017-09-19 | Novira Therapeutics, Inc. | Pyridyl reverse sulfonamides for HBV treatment |
GB201505658D0 (en) | 2015-04-01 | 2015-05-13 | Cancer Rec Tech Ltd | Inhibitor compounds |
EP3108883A1 (en) * | 2015-06-22 | 2016-12-28 | Fundació Institut de Recerca Biomèdica de Bellvitge | Therapeutic uses of non-peptide inhibitors of the calcineurin - nfat signalling pathway |
GB201617103D0 (en) | 2016-10-07 | 2016-11-23 | Cancer Research Technology Limited | Compound |
CN109503518B (zh) * | 2018-11-15 | 2021-03-30 | 中国医学科学院医药生物技术研究所 | 一种取代的双芳香基酰胺化合物及其制备方法和应用 |
WO2021026257A1 (en) * | 2019-08-06 | 2021-02-11 | Empirico Inc. | Prodrugs of alox-15 inhibitors and methods of using the same |
US20230117592A1 (en) * | 2019-12-23 | 2023-04-20 | Sri International | Lipoxygenase inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH373028A (de) * | 1960-08-29 | 1963-11-15 | Geigy Ag J R | Verfahren zur Herstellung neuer Aminobenzoesäurederivate |
DE3743517A1 (de) | 1987-12-22 | 1989-07-06 | Basf Ag | Verfahren zur herstellung von aromatischen hydroxycarbonsaeuren |
DE3816703A1 (de) | 1988-05-17 | 1989-11-30 | Hoechst Ag | Heterocyclisch substituierte phenoxysulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als herbizide oder pflanzenwachstumsregulatoren |
US5041545A (en) | 1989-04-06 | 1991-08-20 | Atochem North America, Inc. | 2-hydroxybenzophenone hydrazides and derivatives thereof |
US5256686A (en) * | 1989-06-27 | 1993-10-26 | Ono Pharmaceutical Co., Ltd. | Phenylalkan(en)oic acid |
US5177246A (en) | 1989-10-02 | 1993-01-05 | Ciba-Geigy Corporation | Hydroxphenylcarboxylic acid esters as stabilizers |
AU648359B2 (en) | 1990-11-22 | 1994-04-21 | Janssen Pharmaceutica N.V. | Isonicotinic acid derivatives |
US5049496A (en) | 1990-12-24 | 1991-09-17 | General Electric Company | Method for microbiologically hydroxylating biphenyl and terphenyl compounds |
US5382690A (en) | 1992-08-11 | 1995-01-17 | Mitsui Toatsu Chemicals, Incorporated | Method for preparing aromatic secondary amino compound |
DE4238994A1 (de) | 1992-11-19 | 1994-05-26 | Basf Ag | Aniline als Markierungsmittel für Mineralöle |
DE4331416A1 (de) | 1993-12-09 | 1995-06-14 | Bayer Ag | Verwendung von Phenylcarbonsäure-amiden als Kristallisationsinhibitoren |
-
1998
- 1998-11-20 AU AU15297/99A patent/AU1529799A/en not_active Abandoned
- 1998-11-20 AT AT98959510T patent/ATE282591T1/de not_active IP Right Cessation
- 1998-11-20 US US09/529,135 patent/US6268387B1/en not_active Expired - Fee Related
- 1998-11-20 NZ NZ502963A patent/NZ502963A/en unknown
- 1998-11-20 KR KR1020007006971A patent/KR20010033470A/ko not_active Application Discontinuation
- 1998-11-20 ES ES98959510T patent/ES2234169T3/es not_active Expired - Lifetime
- 1998-11-20 DE DE69827664T patent/DE69827664T2/de not_active Expired - Fee Related
- 1998-11-20 EP EP98959510A patent/EP1042276B1/en not_active Expired - Lifetime
- 1998-11-20 JP JP2000525370A patent/JP2001526255A/ja not_active Withdrawn
- 1998-11-20 CA CA002300197A patent/CA2300197A1/en not_active Abandoned
- 1998-11-20 BR BR9814327-1A patent/BR9814327A/pt not_active IP Right Cessation
- 1998-11-20 WO PCT/US1998/024688 patent/WO1999032433A1/en active IP Right Grant
- 1998-12-22 UY UY25322A patent/UY25322A1/es unknown
- 1998-12-22 PE PE1998001268A patent/PE20000064A1/es not_active Application Discontinuation
- 1998-12-22 AR ARP980106614A patent/AR024826A1/es unknown
- 1998-12-22 CO CO98076093A patent/CO4990966A1/es unknown
- 1998-12-22 ZA ZA9811805A patent/ZA9811805B/xx unknown
-
2001
- 2001-05-15 US US09/858,089 patent/US6528528B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1999032433A1 (en) | 1999-07-01 |
ZA9811805B (en) | 1999-06-29 |
US6268387B1 (en) | 2001-07-31 |
ATE282591T1 (de) | 2004-12-15 |
EP1042276A1 (en) | 2000-10-11 |
EP1042276B1 (en) | 2004-11-17 |
AU1529799A (en) | 1999-07-12 |
KR20010033470A (ko) | 2001-04-25 |
NZ502963A (en) | 2002-06-28 |
DE69827664T2 (de) | 2005-12-08 |
JP2001526255A (ja) | 2001-12-18 |
BR9814327A (pt) | 2000-10-03 |
AR024826A1 (es) | 2002-10-30 |
US6528528B2 (en) | 2003-03-04 |
US20010031874A1 (en) | 2001-10-18 |
CA2300197A1 (en) | 1999-07-01 |
ES2234169T3 (es) | 2005-06-16 |
DE69827664D1 (de) | 2004-12-23 |
UY25322A1 (es) | 2004-07-30 |
PE20000064A1 (es) | 2000-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4990966A1 (es) | Compuestos de tiourea y benzamida, composiciones y metodos para tratar y prevenir enfermedades inflamatorias y arteros- clerosis | |
NO148884C (no) | Trijodert isofthalsyrediamid og anvendelse derav som roentgenkontrastmiddel. | |
DE3275294D1 (en) | N-phenylsulfonyl-n'-pyrimidinyl and ditto triazinyl ureas | |
MY102027A (en) | Leukotriene antagonists | |
MY100040A (en) | Substituted azabicyclo compounds. | |
CA2047848A1 (en) | Azabicyclo derivatives | |
DK1117297T3 (da) | Syntetiske analoger af ecteinascidin-743 | |
PE20000942A1 (es) | Derivados de amida, carbamato y urea | |
ES557582A0 (es) | Un procedimiento para preparar derivados de (benzoil-4-piperidinil-1)-2-fenil-1-alcanoles | |
RS51042B (sr) | Derivati benzoksazina kao 5-ht6 modulatori i njihove primene | |
PT81890B (pt) | Processo para a preparacao de composicoes herbicidas que contem um composto do tipo n-(fosfonometilglicil)-sulfonilamina | |
FI935517A0 (fi) | Fenoxi- och fenoxialkylpiperidiner som virusmotverkande medel | |
FI871360A (fi) | Nya fenoxialkylkarboxylsyraderivat foerfarande foer deras framstaellning och laekemedel innehaollande dessa foereningar. | |
DK276386A (da) | Sulfonsyreestere samt deres fremstilling og anvendelse | |
DK119684A (da) | Quinoloncarboxylsyrer og disses anvendelse som baktericider | |
AR024222A1 (es) | Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen | |
DE60011916D1 (de) | Heteroaryloxypropanolamine als beta3-adrenergischer rezeptor-agonisten | |
DK0719760T3 (da) | Naphthalenderivater og deres anvendelse som PGE2-agonister og -antagonister | |
ES525796A0 (es) | Procedimiento para la preparacion de 2-amino-3,5-dibromobencilaminas | |
GB1368699A (en) | Benzoyl ureas and process for their manufacture | |
SE7608592L (sv) | Nya homoftalimider | |
PT87162A (pt) | Process for the preparation of a pyridil alcanoic acid compoundcontainig a sulphonamido group and of pharmaceutical compositions therewith | |
GB1445595A (en) | 4-aminoquinoline derivatives and intermediates for their pre paration | |
PE20030434A1 (es) | COMPUESTO DE ß-CETOAMIDA | |
PT84161B (pt) | Processo para a preparacao de derivados de 3-acilaminometil-imidazo-{1,2-a}-piridinas e de composicoes farmaceuticas que os contem |